HomeNewsOutsourcing

Natco Pharma's partner Breckenridge Pharma launches generic Afinitor in US market

Natco Pharma's partner Breckenridge Pharma launches generic Afinitor in US market

Natco Pharma Limited announced that its marketing partner Breckenridge Pharmaceutical, Inc., US has launched the 10mg strength of everolimus tablets (generic for Afinitor) in the US market.

The US Food and Drug Administration previously granted final approval of this Abbreviated New Drug Application.

According to industry sales data, the 10mg strength of Afinitor generated annual sales of $392 million during the twelve months ending July 2021.

Breckenridge previously launched everolimus tablets in 2.5mg, 5mg and 7.5mg strengths during the first quarter of 2021 in the US market.

More news about: outsourcing | Published by Darshana | October - 01 - 2021

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology